The company's latest set of earnings, it seems, wasn't outstanding enough for investors.
News & Analysis: Opko Health
The company turned a profit during the second quarter.
Investors can pick up a sizable number of shares in great companies without paying a fortune.
Here's why this healthcare company that is testing for COVID-19 in NBA and NFL players is a strong buy.
The arrangement is the latest in a series of collaborations with professional sports organizations.
The company confirmed it will provide coronavirus testing for the National Football League.
Which stock wins in a battle between a COVID-19 testing leader and the top contract manufacturer for COVID-19 vaccines?
The company is rolling out a new COVID-19 testing program for businesses.
Its BioReference subsidiary is rolling out testing with five locations -- one in each of NYC's boroughs -- but will quickly expand its footprint.
The company's sales slipped in the quarter despite a ramp-up in COVID-19 testing demand.